The public issue comprises a fresh issue of 50 lakh shares and an offer for sale (OFS) of 91 lakh shares by Rajesh Vasantray ...

After layoffs this fall, Mythic Therapeutics is winding down, putting all its assets up for sale and terminating its only clinical trial. “The company is in the process of winding down and selling ...

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current momentum—as long as strong clinical data continue to be rewarded and companies ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Hedge funds betting on drugs stocks have made bumper profits this year, as a recent wave of deals by big ...

SkyDeck and Bakar Labs to Highlight 24 Emerging Companies From Across Campus, Illustrating Berkeley’s ‘Open Bazaar’ Model for Scientific and Entrepreneurial Innovation BERKELEY, CA / ACCESS Newswire / ...

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- ...

An illustration of a dual-capped mRNA and a capped circular RNA to augment cap-dependent translation initiation using branched topology. Chen et al. have developed a precise chemo-enzymatic method to ...